tradingkey.logo
tradingkey.logo
検索

STRATA Skin Sciences Inc

SSKN
ウォッチリストに追加
0.190USD
0.0000.00%
終値 05/15, 16:00ET15分遅れの株価
718.36K時価総額
損失額直近12ヶ月PER

STRATA Skin Sciences Inc

0.190
0.0000.00%

詳細情報 STRATA Skin Sciences Inc 企業名

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

STRATA Skin Sciences Incの企業情報

企業コードSSKN
会社名Strata Skin Sciences Inc
上場日Oct 28, 2005
最高経営責任者「CEO」Rafaeli (Dolev)
従業員数106
証券種類Ordinary Share
決算期末Oct 28
本社所在地5 Walnut Grove Drive, Suite 140
都市HORSHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号19044
電話番号12156193200
ウェブサイトhttps://www.strataskinsciences.com/
企業コードSSKN
上場日Oct 28, 2005
最高経営責任者「CEO」Rafaeli (Dolev)

STRATA Skin Sciences Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
--
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
20.00K
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
20.00K
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
20.00K
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
7.50K
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
2.00K
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
--
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
20.00K
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
20.00K
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
20.00K
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
7.50K
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
2.00K
--

収益内訳

通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States (Country)
20.58M
67.06%
Other foreign
4.86M
15.84%
China
3.35M
10.93%
Middle East
1.90M
6.18%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Thu, May 14
更新時刻: Thu, May 14
株主統計
種類
株主統計
株主統計
比率
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Rafaeli (Dolev)
2.43%
他の
50.89%
株主統計
株主統計
比率
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Rafaeli (Dolev)
2.43%
他の
50.89%
種類
株主統計
比率
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.61%
Hedge Fund
8.27%
Corporation
6.21%
Individual Investor
3.76%
Investment Advisor
0.97%
他の
46.68%

機関投資家保有株

更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
38
2.57M
43.62%
-87.87K
2025Q4
39
2.56M
43.55%
-107.46K
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Accelmed Growth Partners Management Ltd
1.44M
24.49%
--
--
Sep 04, 2025
22NW, LP
537.00K
9.12%
--
--
Dec 31, 2025
Nantahala Capital Management, LLC
403.92K
6.86%
--
--
Dec 31, 2025
Lincoln Alternative Strategies LLC
365.85K
6.21%
+365.85K
--
Sep 03, 2025
Rafaeli (Dolev)
143.16K
2.43%
--
--
Dec 31, 2025
Renaissance Technologies LLC
63.83K
1.08%
-37.70K
-37.13%
Dec 31, 2025
Abante Asesores Gestión, S.G.I.I.C., S.A.
52.39K
0.89%
+52.39K
--
Dec 31, 2025
Allgeier (Christina L)
20.00K
0.34%
+20.00K
--
Dec 31, 2025
Geiger (Uri)
20.00K
0.34%
+20.00K
--
Dec 31, 2025
Gov (Shmuel)
20.00K
0.34%
--
--
Dec 31, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
日付
配当落ち日
種類
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
KeyAI